A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study)
Authors:
- Robert L. BenzRBRobert L. Benz
- Mark R. PressmanMPMark R. Pressman
- Edward T. HovickEHEdward T. Hovick
- Donald D. PetersonDPDonald D. Peterson
- 1 December 1999
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 34 (6) , 1089-1095
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: A study of 133 patients diagnosed with new standard criteriaMovement Disorders, 1997
- Sleep complaints are common in a dialysis unitAmerican Journal of Kidney Diseases, 1995
- Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patientsAmerican Journal of Kidney Diseases, 1995
- Leukocytosis and natural killer cell function parallel neurobehavioral fatigue induced by 64 hours of sleep deprivation.Journal of Clinical Investigation, 1994
- Sleep disordered breathing in ESRD: Acute beneficial effects of treatment with nasal continuous positive airway pressureKidney International, 1993
- Central Nervous System Function in Dialysis Patients: A Practical ApproachSeminars in Dialysis, 1991
- Sleep as a host defense: Its regulation by microbial products and cytokinesClinical Immunology and Immunopathology, 1990
- Sleep apnea syndrome in chronic renal diseaseThe American Journal of Medicine, 1989
- Periodic movements in sleep (nocturnal myoclonus): Relation to sleep disordersAnnals of Neurology, 1980
- Ventricular Fibrillation Occurring on Arousal from Sleep by Auditory StimuliCirculation, 1972